IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
82.12
-0.62 (-0.75%)
Sep 18, 2026, 4:00 PM EDT - Market closed
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, IRADIMED CORPORATION stock has a consensus rating of "Strong Buy" and an average price target of $118. The average 1-year stock price forecast is 43.69% higher than the current stock price, while the lowest is $116 (+41.26%) and the highest is $120 (+46.13%).
Price Target: $118 (+43.69%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 3, 2026.
Analyst Ratings
The average analyst rating for IRADIMED CORPORATION stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $120 | Buy | Reiterates | $120 | +46.13% | Aug 3, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Initiates $116 | Buy | Initiates | $116 | +41.26% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
91.20M
from 83.81M
Increased by 8.81%
Revenue Next Year
101.00M
from 91.20M
Increased by 10.75%
EPS This Year
2.09
from 1.93
Increased by 8.29%
EPS Next Year
2.41
from 2.09
Increased by 15.31%
EPS and Forward PE are based on non-GAAP adjusted numbers.